» Articles » PMID: 39649762

Spontaneous and Induced Degradation of Dermal Fillers: A Review

Overview
Date 2024 Dec 9
PMID 39649762
Authors
Affiliations
Soon will be listed here.
Abstract

Dermal fillers are among the most versatile tools in esthetic medicine. A broad range of temporary, semipermanent, and permanent filler products are on the market. We performed a narrative review on spontaneous and induced degradation of dermal fillers and . Hyaluronic acid-based fillers are the most frequently used temporary fillers. The products differ in their hyaluronic acid content, cross-linking, and rheological parameters. Endogenous hyaluronidase and reactive oxygen species are responsible for the spontaneous degradation of these fillers. Hyaluronidase digests the filler material by cleavage of the -1,4 glycosidic linkage between -acetylglucosamine and -glucuronic acid. The enzyme can be used for treatment of medical and cosmetic adverse events due to hyaluronic acid-based filler. Higher hyaluronidase content and higher degree of cross-linking are major factors contributing to filler persistence over time. Semipermanent fillers are poly-(), -lactic acid and calcium hydroxylapatite. These filler types are decomposed by hydrolysis and osteoclastic enzymes. They usually persist up to 2 years, in single patients even more than 5 years. Sodium thiosulfate can stimulate degradation of calcium hydroxylapatite, but it is slow acting and not effective in case of emergency. Permanent fillers may show some kind of modification , but spontaneous or induced degradation has not been documented. Once implanted the permanent fillers remain lifelong. Intralesional laser treatment supports the removal of permanent filler material as an alternative to surgery. Besides biocompatibility and toxicity, filler materials should also be assessed for degradation to improve patient safety.

Citing Articles

Commentary on "Complications of Collagen Biostimulators in Brazil: Description of Products, Treatments, and Evolution of 55 Cases".

Magacho-Vieira F J Cosmet Dermatol. 2024; 24(2):e16751.

PMID: 39710949 PMC: 11845953. DOI: 10.1111/jocd.16751.

References
1.
Csoka A, Frost G, Stern R . The six hyaluronidase-like genes in the human and mouse genomes. Matrix Biol. 2001; 20(8):499-508. DOI: 10.1016/s0945-053x(01)00172-x. View

2.
Salwowska N, Bebenek K, Zadlo D, Wcislo-Dziadecka D . Physiochemical properties and application of hyaluronic acid: a systematic review. J Cosmet Dermatol. 2016; 15(4):520-526. DOI: 10.1111/jocd.12237. View

3.
Lemperle G, Knapp T, Sadick N, Lemperle S . ArteFill permanent injectable for soft tissue augmentation: I. Mechanism of action and injection techniques. Aesthetic Plast Surg. 2009; 34(3):264-72. PMC: 2872009. DOI: 10.1007/s00266-009-9413-1. View

4.
Wollina U, Wiegand C, Hipler U . CALCIUM HYDROXYLAPATITE MICROSPHERES - BIOCOMPATIBILITY AND CLINICAL EFFECTS. Georgian Med News. 2018; (278):62-68. View

5.
van Loghem J, Yutskovskaya Y, Werschler W . Calcium hydroxylapatite: over a decade of clinical experience. J Clin Aesthet Dermatol. 2015; 8(1):38-49. PMC: 4295857. View